针对自和更远的目标:将Beclin-1的复杂性从生物功能解开到癌症治疗
Jing Ye1, Jin Zhang1, Yanghui Zhu1
1Department of Dermatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Acta pharmaceutica Sinica. B
|December 4, 2023
概括
贝克林-1蛋白调节自和细胞贩运. 本综述探讨了其在癌症中的复杂作用,强调了其作为改善癌症治疗策略的治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 贝克林-1是自途径中的关键蛋白质,作为PI3KC3复合体的支架.
- 贝克林-1涉及瘤发生的各个方面,包括瘤抑制,进展和对治疗的抗性.
- 癌症干细胞 (CSCs) 依赖Beclin-1进行维护,这表明它在癌症复发中的关键作用.
研究的目的:
- 为Beclin-1的结构,功能和监管提供全面的审查.
- 讨论贝克林-1在癌症发展和进展中的双重和经常有争议的作用.
- 总结针对Beclin-1进行癌症治疗的当前策略,并探索未来的治疗潜力.
主要方法:
- 文献综述和对Beclin-1现有研究的综合.
- 对Beclin-1在自诱导和细胞贩运中的参与进行分析.
- 检查Beclin-1对瘤抑制,进展和治疗耐药性的影响.
主要成果:
- 贝克林-1作为PI3KC3的支架的功能对于自至关重要.
- 有证据表明,Beclin-1在癌症中起到多方面的作用,既可以作为瘤抑制剂,也可以作为瘤促进剂.
- 贝克林-1对于CSC维护至关重要,并有助于治疗耐药性.
结论:
- 贝克林-1是自的关键调节剂,在瘤学上具有重要意义.
- 了解Beclin-1的复杂作用对于开发有效的癌症疗法至关重要.
- 准Beclin-1为新的癌症治疗策略提供了一个有希望的途径.
相关概念视频
Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


